Opsonization of Apoptotic Cells by Autologous IC3b Facilitates Clearance by Immature Dendritic Cells, Down-regulates DR and CD86, and Up-regulates CC Chemokine Receptor 7

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2002 Dec 18

PMID 12486098

Citations 76

Authors

Inna Verbovetski

Hila Bychkov

Uriel Trahtemberg

Itzhak Shapira

Mara Hareuveni

Ofira Ben-Tal

Ina Kutikov

Oranit Gill

Dror Mevorach

Affiliations

Soon will be listed here.

Abstract

Immature dendritic cells (iDCs) do not mature after uptake of apoptotic cells and may play a role in the induction of peripheral tolerance to self antigens derived from apoptotic material. The integrins, alphavbeta3, alphavbeta5, and the scavenger receptor, CD36, have been shown to mediate uptake of apoptotic cells by iDCs. However, it is not known whether the complement system, also takes part in this process. In this study we investigated the ability of iDCs to bind to apoptotic cells opsonized by iC3b. Monocyte-derived dendritic cells were offered apoptotic Jurkat cells opsonized by autologous iC3b and labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanineperchlorate. A significant increase (P < 0.001) in the amount of cleared apoptotic cells was seen at low ratios. Despite increased efficiency of uptake, interaction between iC3b-opsonized apoptotic cells and iDCs down-regulated the expression of major histocompatibility complex class II, CD86, CC chemokine receptor (CCR)2, CCR5, and beta2-integrins (P < 0.001), and up-regulated expression of CCR7 (P < 0.001). In addition, iDC maturation responses to CD40L and lipopolysaccharide were significantly inhibited. We conclude that opsonization of apoptotic cells by iC3b induces tolerant iDCs that are able to migrate to lymph nodes.

Citing Articles

Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights.

Hoseinzadeh A, Esmaeili S, Sahebi R, Melak A, Mahmoudi M, Hasannia M Stem Cell Res Ther. 2025; 16(1):33.

PMID: 39901306 PMC: 11792531. DOI: 10.1186/s13287-025-04158-z.

Striking a balance: new perspectives on homeostatic dendritic cell maturation.

Bosteels V, Janssens S Nat Rev Immunol. 2024; 25(2):125-140.

PMID: 39289483 DOI: 10.1038/s41577-024-01079-5.

Efferocytosis in dendritic cells: an overlooked immunoregulatory process.

Ma Y, Jiang T, Zhu X, Xu Y, Wan K, Zhang T Front Immunol. 2024; 15:1415573.

PMID: 38835772 PMC: 11148234. DOI: 10.3389/fimmu.2024.1415573.

Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats.

Ankri C, Hershkovitz O, Hershkovitz L, Brami M, Levy R, Sarig H Pharmaceutics. 2024; 16(3).

PMID: 38543320 PMC: 10975356. DOI: 10.3390/pharmaceutics16030426.

Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model.

Kamegai N, Kim H, Suzuki Y, Fukui S, Kojima H, Maruyama S Clin Exp Immunol. 2023; 214(2):209-218.

PMID: 37549240 PMC: 10714190. DOI: 10.1093/cei/uxad088.

References

Marth T, Kelsall B . Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med. 1997; 185(11):1987-95. PMC: 2196332. DOI: 10.1084/jem.185.11.1987. View

Coxon A, Rieu P, Barkalow F, Askari S, Sharpe A, von Andrian U . A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity. 1996; 5(6):653-66. DOI: 10.1016/s1074-7613(00)80278-2. View

Rubartelli A, Poggi A, Zocchi M . The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur J Immunol. 1997; 27(8):1893-900. DOI: 10.1002/eji.1830270812. View

Albert M, Sauter B, Bhardwaj N . Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998; 392(6671):86-9. DOI: 10.1038/32183. View

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

Botto M, DellAgnola C, Bygrave A, Thompson E, Cook H, Petry F . Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998; 19(1):56-9. DOI: 10.1038/ng0598-56. View

Sutterwala F, Noel G, Salgame P, Mosser D . Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med. 1998; 188(1):217-22. PMC: 2525554. DOI: 10.1084/jem.188.1.217. View

Aplin A, Howe A, Alahari S, Juliano R . Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev. 1998; 50(2):197-263. View

Dieu M, Vanbervliet B, Vicari A, Bridon J, OLDHAM E, Briere F . Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998; 188(2):373-86. PMC: 2212459. DOI: 10.1084/jem.188.2.373. View

10.

Mevorach D, Zhou J, Song X, Elkon K . Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med. 1998; 188(2):387-92. PMC: 2212450. DOI: 10.1084/jem.188.2.387. View

11.

Sozzani S, Allavena P, DAmico G, Luini W, Bianchi G, Kataura M . Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol. 1998; 161(3):1083-6. View

12.

Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y . EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol. 1998; 161(6):3096-102. View

13.

Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay C . Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol. 1998; 28(9):2760-9. DOI: 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N. View

14.

Albert M, Pearce S, Francisco L, Sauter B, Roy P, Silverstein R . Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 1998; 188(7):1359-68. PMC: 2212488. DOI: 10.1084/jem.188.7.1359. View

15.

Albert M, Darnell J, Bender A, Francisco L, Bhardwaj N, Darnell R . Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med. 1998; 4(11):1321-4. DOI: 10.1038/3315. View

16.

Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M . Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med. 1998; 188(11):2163-73. PMC: 2212389. DOI: 10.1084/jem.188.11.2163. View

17.

Mevorach D, Mascarenhas J, Gershov D, Elkon K . Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med. 1998; 188(12):2313-20. PMC: 2212421. DOI: 10.1084/jem.188.12.2313. View

18.

Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, Rescigno M . Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med. 1999; 189(2):371-80. PMC: 2192989. DOI: 10.1084/jem.189.2.371. View

19.

Sallusto F, Lanzavecchia A . Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med. 1999; 189(4):611-4. PMC: 2192930. DOI: 10.1084/jem.189.4.611. View

20.

Kellermann S, Hudak S, Oldham E, Liu Y, McEvoy L . The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol. 1999; 162(7):3859-64. View